Coulter Partners provides leadership consultancy to Life Sciences, Health and Technology innovation businesses globally. We build teams that change the world and create a better future. Over 20 years we have delivered on 1000s of assignments across the USA, Canada, UK/Europe, and APAC, advising companies and investors on how to shape and hire their boards and leadership teams. We strongly impact value and growth. Our 110 experts operate uniquely as one global team. With our track record, AI, bespoke systems and wealth of data, we fuel the ability of investors, boards and executive teams to deliver value from innovation.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Search consultants continue to say that there is an unprecedented opportunity for visionary healthcare/life sciences leaders to redefine the future of the industry. A shifting economic climate and the rapid pace of innovation have fueled many changes in the healthcare industry through acquisitions, divestitures, and new company formations. The pandemic accelerated the adoption of technologies
Life sciences recruiting specialist Coulter Partners has recruited Jose Lora as chief scientific officer and Heather Hirsch as SVP of translational science and cancer biology of hC Bioscience. “It was our pleasure to work with Coulter Partners and we thank the team for their professionalism and outstanding support in making these appointments, both of which are critical to
Life sciences recruiting specialist Coulter Partners has formed a partnership with the Institute of Neurodiversity (ION). As a global neurodiversity changemaking organization and community, ION looks to foster awareness, acceptance, and appreciation of neurodiversity. They work with organizations, governments, the third sector, educators, and policymakers to raise awareness and advocate for policies that support neurominority inclusion. “We
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Michael Akoh as the new chief executive officer of ArcticZymes Technologies, a Norwegian life sciences company. Past CEO Jethro Holter stepped down for personal reasons. “We are very fortunate to have engaged Michael as our next CEO,” said Marie Roskrow, ArcticZymes’ chairman of the board. “Coulter Partners ran
Coulter Partners recently partnered with hC Bioscience and is pleased to announce the placements of Jose Lora, Ph.D. as Chief Scientific Officer (CSO), and Heather Hirsch, Ph.D. as SVP of Translational Science and Cancer Biology. hC Bioscience is a pioneering biotech company dedicated to advancing tRNA-based therapies, a new class of treatments that target disease-causing
24 August 2023 – Coulter Partners recently partnered with the Cell and Gene Therapy Catapult (CGT Catapult) announcing the placement of Jeanette Evans as Chief Business Officer (CBO), taking over from Sharon Brownlow, with effect in August 2023. CGT Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene
Coulter Partners announces the placement of Michael Akoh, ArcticZymes’ new Chief Executive Officer. ArcticZymes Technologies ASA (OSE:AZT) is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Commenting on his appointment at ArcticZymes Michael Akoh said: “I am delighted to
Coulter Partners recently announced the placements at Dalriada of Adam Davenport, Ph.D. as Chief Research & Development Officer (CRDO), and Frosty Loechel, Ph.D. as SVP Biology, Discovery Strategy group. Dalriada, through its TURN-KEY™ Drug Discovery services model, provides a full suite of drug discovery, medicinal chemistry, and intellectual property services for semi-virtual, lean biotechnology clients
Coulter Partners is pleased to announce the placement of Gerben van ‘t Klooster as Chief Development Officer (CDO) of TargED Biopharmaceuticals. TargED is a biotechnology company dedicated to the development of innovative therapies for rare diseases that develops first-in-class biological drugs to improve the treatment of thrombosis. Gerben van ‘t Klooster, Ph.D. is a seasoned
Blogs
Top hires for VC & PE portfolio companies Q1-2024
D, E & I: VIEWS FROM LEADERSHIP SERIES – Lene Gerlach, Founder and Chair of Women in Life Science Denmark (WiLD), and Partner at Eir Ventures
D, E & I: VIEWS FROM LEADERSHIP SERIES – Yael Gruenbaum-Cohen, Partner at aMoon and Founder of WE@HealthTech
Top hires for VC & PE portfolio companies Q4-2023
Top global hires for large-cap, mid-cap and public companies H2-2023
Top hires for VC & PE portfolio companies Q3-2023
Top hires for VC & PE portfolio companies Q2-2023
Top global hires for large-cap, mid-cap and public companies H1-2023
Top hires for VC & PE portfolio companies Q1-2023
D, E & I: Views From Leadership Series – Charlotte Valeur, Founder of Institute Of Neurodiversity, ION
Top hires for VC & PE portfolio companies Q4-2022
Top global hires for large-cap, mid-cap and public companies H2-2022
Diversity, Equity, & Inclusion: Views From Leadership Series- Quita Highsmith, Vice President and Chief Diversity Officer at Genentech
Diversity, Equity & Inclusion: Views from Leadership-Tomoko Adachi
Diversity, Equity & Inclusion: Views from Leadership-Corinne Le Goff